Schizophrenia is a major psychiatric disorder, or cluster of disorders, characterised by psychotic symptoms that alter a person’s perception, thoughts, affect and behaviour (NICE, 2009). Tai and Turkington (2009) define Cognitive Behaviour Therapy (CBT) as an evidence-based talking therapy that attempts cognitive and behavioural change based on an individualised formulation of a client’s personal history, problems and world views. CBT as a treatment for schizophrenia can be understood within a wider framework of CBT as applied to a range of mental disorders such as anxiety, post traumatic stress disorder (PTSD), and depression (Tai and Turkington, 2009). CBT was built on behavioural principles that emphasised clear relationships between cognition, physiology and emotion (Beck, 1952). This essay will analyse CBT as a therapy for individual suffering from schizophrenia. It will discuss briefly the historical background and the development of CBT, the aims and principles, the evidence base of the strengths and weaknesses of the therapy. It will discuss as well the implication to mental health nursing practice. The focus of this essay is on intervention and psychosocial in nature which will be brought together in the conclusion. According to Gamble and Brennan (2000), the effectiveness of medication for schizophrenia to relieve patients from psychotic symptoms is limited. Although patients have adequate medication, some received little or no benefit from it and almost half of them still experience psychotic symptoms. They are also more likely to suffer relapse (Gamble and Brennan, 2000). Furthermore, Valmaggia, et al. (2005) found that 50% of patients who fully adhere to anti-psychotic medication regimes still have ongoing positi... ... middle of paper ... ...zophrenia: 12-month follow-up. Br J Psychiatry; 174:500–504 Turkington, D, Kingdon, D, & Rathod, S (2006), 'Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia', British Journal of Psychiatry, 11, 1, pp. 36-40 Turkington D, Dudley R, Warman DM, and Beck AT (2006) Cognitive-Behavioural Therapy for Schizophrenia: A Review Focus, Spring 2006; 4: 223 - 233. Valmaggia LR, van der Gaag M, Tarrier N, Pijnenborg M, Slooff CJ. (2005) Cognitive–behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication The British Journal of Psychiatry (2005) 186: 324-330 Wykes T, Steel C, Everitt B and Tarrier N (2008) Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor Schizophrenia Bulletin 34(3): 523-537
Tsuang, M. T., Faraone, S. V., & Glatt, S. J. (2011). Schizophrenia. New York: Oxford University Press.
5). While Schizophrenia has been most commonly treated with the use of anti-psychotic medications for decades, cognitive therapy provides an alternative and cognitive psychologist would undoubtedly disagree with Elizabeth’s mother’s decision to medicate her. The way a cognitive psychologist would treat Elizabeth is by the use of therapy and encouraging her to talk about her behaviors and problems as they do not believe that Schizophrenia “is a biological illness that one either has or does not have” (Freeman, 2014, para. 7) and instead the symptoms such as hallucinations or delusions simply represent the patient’s thoughts and feelings (Freeman, 2014). For example, “an individual troubled by hearing voices will be helped to understand what’s triggering these voices, and to develop a more confident, empowering relationship with them” (Freeman, 2014, para.
Stahl, S. M., & Mignon, L. (2010). Antipsychotics: Treating psychosis, mania and depression (2nd ed.).
Stern, Richard. "Behavioural-Cognitive Psychotherapy Training for Psychiatrists." Pb.rcpsych.org. The Royal College of Psychiatrists, 1993. Web. 24 Feb. 2014.
-Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005. Web.
Schizophrenia is a deteriorating progressive disease, consequently, it is resistant to treatment for the individual suffering schizophrenia. (Catts & O’Toole, 2016). In most cases the individuals suffering from schizophrenia, are resistive to treatment, in most cases, individuals suffering from schizophrenia, and are resistive in taking antipsychotics. (Catts & O’Toole, 2016). Jeremy doesn’t see himself as a “schizophrenic”, he states that “he’s happy naturally”, and often he’s observed playing the guitar and doing painting in his room. Weekly, he has an intramuscular medication to treat his disorder, crediting the support of his wife. It is indicated that the morality rate, in patients suffering from schizophrenia is higher, despite the considerable resources available, in Australia. New data show that in 20 countries, including Australia, only 13.5% meet the recovery criteria, which means that 1or 2 patients in every 100, will meet this criteria per year. (Catts & O’Toole, 2016). This means that there’s a decline in providing support and services to individuals like Jeremy suffering from a mental illness such as Schizophrenia. Many individuals become severely ill before they realise they need medical treatment, and when receiving treatment it is usually short-term. (Nielssen, McGorry, Castle & Galletly, 2017). The RANZCP guidelines highlights that
Schizophrenia is a severe and debilitating mental disorder that affects approximately 1% of the population worldwide (Mamani, Gurak, & Suro, 2014). Schizophrenia is characterized by positive symptoms, including hallucinations, delusions and disorganized thinking and speech, as well as negative symptoms, including flat affect, apathy, lack of motivation or drive and social isolation. Schizophrenia is also associated with cognitive, social, and functional deficits and abnormalities in mood, such as anxiety and depression (Larson, Walker, & Compton, 2010). Due to the chronic and impairing nature of schizophrenia, recent research has focused on identifying and treating individuals in the prodromal phase of illness, also referred to as the at-risk mental state or ARMS (Tiffin & Welsh, 2013). The prodrome or ARMS refers to the period of time beginning with declines in areas including cognition and social, emotional and perceptual functioning, and ending with the onset of a schizophrenia spectrum disorder (White, Anjum, & Schulz, 2006). Identification and treatment of the prodromal period is of utmost importance, as research has shown that a longer duration of untreated psychosis (DUP) is associated with poorer prognosis for patients (Kaur & Cadenhead, 2010; Larson et al., 2010).
Addington, J., Piskulic, D., & Marshall, C. (n.d). Psychosocial Treatments for Schizophrenia. Current Directions In Psychological Science, 19(4), 260-263.
A quick description of the Phenomenon of Interest that will be the basis of the discussion for this paper is about the challenges of medication adherence to antipsychotic medications in patient’s diagnosed with schizophrenia and how it increases relapse and readmission rate (Maddad, Brain, & Scott, 2014). It also talks about their cognitive impairment, which is a characteristic of
There are several people every year that are diagnosed with a mental disorder. In the world’s entire population, more than one percent of people have been diagnosed with schizophrenia (Brain and Behavior Research Foundation). When thinking of the billions of people in the world, it might not seem like that many people but once the number of those diagnosed is calculated it seems much larger. Currently there are more than seventy million people in the world that have been diagnosed with schizophrenia, only diagnosed. There are probably several more people who have this disorder and have not been diagnosed or are unable to obtain the resources to be diagnosed.
Classical antipsychotic treatments are commonly used to treat schizophrenic patients with major positive symptoms of schizophrenia, such as Thorazine, Haldol, and Stelazine (Gleitman et al., 2011). Antipsychotic treatments are usually administered with a variety of psychosocial treatments including social skills training, vocational rehabilitation, supported employment, family therapy, or individual therapy (Barlow & Durand, 2014). This is to reduce relapse and help the patient improve their skills in deficits and comply in consuming the
Schizophrenia is a life-long illness that requires a person and their family to really care for them. Many advances have been made in treatment and many patients can now live satisfying and significant life in the community.
...ected over another because it has less chance of damaging a diseased liver, worsening a heart condition, or affecting a patient’s high blood pressure. For all the benefits that anti-psychotic drugs provide, clearly they are far from ideal. Some patients will show marked improvement with drugs, while others might be helped only a little, if at all. Ideally, drugs soon will be developed to treat successfully the whole range os schizophrenia symptoms. Roughly one third of schizophrenic patients make a complete recovery and have no further recurrence, one third have recurrent episodes of the illness, and one third deteriorate into chronic schizophrenia with severe disability (Kass, 206).
Wright, B., Williams, C. & Garland, A. (2002). Using the five areas cognitive–behavioural therapy model with psychiatric patients. Retrieved 04/07, 2014, from http://apt.rcpsych.org/content/8/4/307.full
Turkington, D & Dudley, R 2006, ‘Cognitive-behavioral therapy for schizophrenia: A review,’ Focus, vol. 4, pp. 223-233.